Do you want to read an article? Please log in or register.
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
Diabetes - GeneralType 2 DiabetesLipids
COMMENTED
Related content
COMMENTED
Diabetes - GeneralType 2 DiabetesDiabetes and Pregnancy
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Diabetologia.
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group
doi: 10.1007/s00125-017-4361-9.
COMMENTED
Pediatric Diabetes
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results
Pediatr Diabetes.
Winkler C, Haupt F, Heigermoser M, Zapardiel-Gonzalo J, Ohli J, Faure T, Kalideri E, Hommel A, Delivani P, Berner R, Kordonouri O, Roloff F, von dem Berge T, Lange K, Oltarzewski M, Glab R, Szypowska A, Snape MD, Vatish M, Todd JA, Larsson HE, Ramelius A, Kördel JÅ, Casteels K, Paulus J, Ziegler AG, Bonifacio E, GPPAD Study Group.
doi: 10.1111/pedi.12870.
Diabetes - GeneralType 2 Diabetes
Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials
Lancet Diabetes Endocrinol.
Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS
doi: 10.1016/
Type 2 Diabetes
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
Diabetes Care.
Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D, Diabetes Prevention Program Research Group.
doi: 10.2337/dc19-0244.
Diabetes - General
Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium
Circulation.
Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff MJ, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M; Diabetes Prevention Program Research Group
doi: 10.1161/CIRCULATIONAHA.
COMMENTED
Diabetic Complications
Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register
Diabetes Care.
Read SH, van Diepen M, Colhoun HM, Halbesma N, Lindsay RS, McKnight JA, McAllister DA, Pearson ER, Petrie JR, Philip S, Sattar N, Woodward M, Wild SH; Scottish Diabetes Research Network Epidemiology Group
doi: 10.2337/dc18-0578.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use
JAMA Intern Med.
Karter AJ, Warton EM, Lipska KJ, Ralston JD, Moffet HH, Jackson GG, Huang ES, Miller DR
doi: 10.1001/
COMMENTED
Diabetes - GeneralType 2 Diabetes
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care
Kriska AM, Rockette-Wagner B, Edelstein SL, Bray GA, Delahanty LM, Hoskin MA, Horton ES, Venditti EM, Knowler WC, DPP Research Group.
doi: 10.2337/dc20-1129
Diabetes - GeneralType 2 DiabetesGlycemic Control
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation
Diabetes Care.
Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group
doi: 10.2337/dc17-1116.